Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, pitolisant (Wakix®) cannot be endorsed for use within NHS Wales in adults for the treatment of narcolepsy with or without cataplexy. |
||
|
||
Medicine details |
||
| Medicine name | pitolisant (Wakix®) | |
| Formulation | 4.5 mg film-coated tablet, 18 mg film-coated tablet | |
| Reference number | 2967 | |
| Indication | For the treatment of narcolepsy with or without cataplexy. |
|
| Company | Lincoln Medical Ltd | |
| BNF chapter | Central nervous system | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | 26/07/2016 | |
| Date of issue | 27/07/2016 | |